Sarasota company applies for Alzheimer's drug patent

A Sarasota biopharmaceutical company is applying for a patent for an Alzheimer’s drug. Silo Pharma, based on North Washington Boulevard, was provided with the exclusive license to the drug by Columbia University, according to a statement.

The company says it is filing an April 28 application with the U.S. Patent and Trademark Office focused on SPC-14, which is a neurology drug administered through an intranasal compound. By targeting certain receptor molecules, it can reduce certain cognitive and neuropsychiatric Alzheimer's symptoms.

“Early pre-clinical studies of SPC-14 have demonstrated the drug’s potential to improve and restore cognitive memory function,” Silo Pharma CEO Eric Weisblum says in a statement.